These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
11-2481903
|
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
1450 Broadway, New York, NY
|
10018
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Large accelerated filer
x
|
Accelerated filer
¨
|
|
Non
- accelerated filer
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
¨
|
|
Page No.
|
||
|
Part I.
|
Financial
Information
|
3
|
|
Item 1.
|
Financial
Statements
|
3
|
|
Condensed
Consolidated Balance Sheets – September 30, 2010 (unaudited) and
December 31, 2009
|
3
|
|
|
Unaudited
Condensed Consolidated Income Statements – Three and Nine Months Ended
September 30, 2010 and 2009
|
4
|
|
|
Unaudited
Condensed Consolidated Statement of Stockholders' Equity – Nine Months
Ended September 30, 2010
|
5
|
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows - Nine Months Ended
September 30, 2010 and 2009
|
6
|
|
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
8
|
|
|
Item 2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
23
|
|
Item 3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
29
|
|
Item 4.
|
Controls
and Procedures
|
30
|
|
Part II.
|
Other
Information
|
30
|
|
Item 1.
|
Legal
Proceedings
|
30
|
|
Item 1A.
|
Risk
Factors
|
30
|
|
Item 2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
34
|
|
Item 6.
|
Exhibits
|
35
|
|
Signatures
|
36
|
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
(Unaudited)
|
||||||||
|
Assets
|
||||||||
|
Current
Assets:
|
||||||||
|
Cash
(including restricted cash of $2,872 in 2010 and $6,163 in
2009)
|
$ | 97,455 | $ | 201,544 | ||||
|
Accounts
receivable
|
73,492 | 62,667 | ||||||
|
Deferred
income tax assets
|
1,875 | 1,886 | ||||||
|
Other
assets - current
|
20,872 | 14,549 | ||||||
|
Total
Current Assets
|
193,694 | 280,646 | ||||||
|
Property
and equipment:
|
||||||||
|
Furniture,
fixtures and equipment
|
12,534 | 9,060 | ||||||
|
Less:
Accumulated depreciation
|
(3,583 | ) | (2,611 | ) | ||||
| 8,951 | 6,449 | |||||||
|
Other
Assets:
|
||||||||
|
Restricted
cash
|
15,866 | 15,866 | ||||||
|
Marketable
securities
|
7,284 | 6,988 | ||||||
|
Goodwill
|
189,641 | 170,737 | ||||||
|
Trademarks
and other intangibles, net
|
1,402,257 | 1,254,689 | ||||||
|
Deferred
financing costs, net
|
3,536 | 4,803 | ||||||
|
Investments
and joint ventures
|
57,177 | 36,568 | ||||||
|
Other
assets – non-current
|
49,558 | 25,867 | ||||||
| 1,725,319 | 1,515,518 | |||||||
|
Total
Assets
|
$ | 1,927,964 | $ | 1,802,613 | ||||
|
Liabilities
and Stockholders' Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Accounts
payable and accrued expenses
|
$ | 36,382 | $ | 24,446 | ||||
|
Deferred
revenue
|
19,627 | 14,802 | ||||||
|
Current
portion of long-term debt
|
92,744 | 93,251 | ||||||
|
Other
liabilities - current
|
4,000 | - | ||||||
|
Total
current liabilities
|
152,753 | 132,499 | ||||||
|
Non-current
deferred income taxes
|
130,804 | 117,090 | ||||||
|
Long-term
debt, less current maturities
|
508,430 | 569,128 | ||||||
|
Long-term
deferred revenue
|
10,632 | 11,831 | ||||||
|
Other
liabilities – non-current
|
20,004 | 2,293 | ||||||
|
Total
Liabilities
|
822,623 | 832,841 | ||||||
|
Commitments
and contingencies
|
||||||||
|
Stockholders'
Equity
|
||||||||
|
Common
stock, $.001 par value shares authorized 150,000; shares
issued 73,780 and 72,759 respectively
|
74 | 73 | ||||||
|
Additional
paid-in capital
|
744,349 | 725,504 | ||||||
|
Retained
earnings
|
272,193 | 195,469 | ||||||
|
Accumulated
other comprehensive loss
|
(3,602 | ) | (4,032 | ) | ||||
|
Less:
Treasury stock – 1,357 and 1,219 shares at cost,
respectively
|
(8,360 | ) | (7,861 | ) | ||||
|
Total
Iconix Stockholders’ Equity
|
1,004,654 | 909,153 | ||||||
|
Non-controlling
interest
|
100,687 | 60,619 | ||||||
|
Total
Stockholders’ Equity
|
1,105,341 | 969,772 | ||||||
|
Total
Liabilities and Stockholders' Equity
|
$ | 1,927,964 | $ | 1,802,613 | ||||
|
Three Months Ended September
30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Licensing
and other revenue
|
$ | 96,887 | $ | 59,367 | $ | 244,604 | $ | 166,276 | ||||||||
|
Selling,
general and administrative expenses
|
42,032 | 21,023 | 90,719 | 54,661 | ||||||||||||
|
Expenses
related to specific litigation
|
33 | - | 240 | 137 | ||||||||||||
|
Operating
income
|
54,822 | 38,344 | 153,645 | 111,478 | ||||||||||||
|
Other
expenses
|
||||||||||||||||
|
Interest
expense
|
10,665 | 9,787 | 32,366 | 30,336 | ||||||||||||
|
Interest
and other income
|
(902 | ) | (766 | ) | (2,680 | ) | (1,941 | ) | ||||||||
|
Equity
earnings on joint ventures
|
(25 | ) | (2,559 | ) | (2,242 | ) | (3,366 | ) | ||||||||
|
Other
expenses - net
|
9,738 | 6,462 | 27,444 | 25,029 | ||||||||||||
|
Income
before income taxes
|
45,084 | 31,882 | 126,201 | 86,449 | ||||||||||||
|
Provision
for income taxes
|
13,252 | 11,428 | 40,042 | 31,055 | ||||||||||||
|
Net
income
|
$ | 31,832 | $ | 20,454 | $ | 86,159 | $ | 55,394 | ||||||||
|
Less:
Net income attributable to non-controlling interest
|
$ | 4,423 | $ | - | $ | 9,435 | $ | - | ||||||||
|
Net
income attributable to Iconix Brand Group, Inc.
|
$ | 27,409 | $ | 20,454 | $ | 76,724 | $ | 55,394 | ||||||||
|
Earnings
per share:
|
||||||||||||||||
|
Basic
|
$ | 0.38 | $ | 0.29 | $ | 1.07 | $ | 0.87 | ||||||||
|
Diluted
|
$ | 0.37 | $ | 0.28 | $ | 1.03 | $ | 0.83 | ||||||||
|
Weighted
average number of common shares outstanding:
|
||||||||||||||||
|
Basic
|
72,326 | 71,336 | 72,013 | 63,850 | ||||||||||||
|
Diluted
|
74,920 | 74,070 | 74,632 | 66,426 | ||||||||||||
|
Accumulated
|
||||||||||||||||||||||||||||||||
|
Additional
|
Other
|
Non-
|
||||||||||||||||||||||||||||||
|
Common Stock
|
Paid-in
|
Retained
|
Comprehensive
|
Treasury
|
Controlling
|
|||||||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Earnings
|
Loss
|
Stock
|
Interest
|
Total
|
|||||||||||||||||||||||||
|
Balance
at January 1, 2010
|
72,759 | $ | 73 | $ | 725,504 | $ | 195,469 | $ | (4,032 | ) | $ | (7,861 | ) | $ | 60,619 | $ | 969,772 | |||||||||||||||
|
Shares
issued on exercise of stock options
|
349 | 1,006 | 1,006 | |||||||||||||||||||||||||||||
|
Shares
issued on vesting of restricted stock
|
75 | - | ||||||||||||||||||||||||||||||
|
Shares
issued for earn-out on acquisition
|
597 | 1 | 9,688 | 9,689 | ||||||||||||||||||||||||||||
|
Tax
benefit of stock option exercises
|
1,589 | 1,589 | ||||||||||||||||||||||||||||||
|
Compensation
expense in connection with restricted stock and stock
options
|
6,562 | 6,562 | ||||||||||||||||||||||||||||||
|
Shares
repurchased on vesting of restricted stock and exercise of stock
options
|
(499 | ) | (499 | ) | ||||||||||||||||||||||||||||
|
Comprehensive
income:
|
||||||||||||||||||||||||||||||||
|
Net
income
|
76,724 | 9,435 | 86,159 | |||||||||||||||||||||||||||||
|
Realization
of cash flow hedge, net of tax
|
134 | 134 | ||||||||||||||||||||||||||||||
|
Change
in fair value of securities, net of tax
|
296 | 296 | ||||||||||||||||||||||||||||||
|
Total
comprehensive income
|
86,589 | |||||||||||||||||||||||||||||||
|
Distributions
to joint ventures
|
(2,745 | ) | (2,745 | ) | ||||||||||||||||||||||||||||
|
Non-controlling
interest of acquired companies
|
33,378 | 33,378 | ||||||||||||||||||||||||||||||
|
Balance
at September 30, 2010
|
73,780 | $ | 74 | $ | 744,349 | $ | 272,193 | $ | (3,602 | ) | $ | (8,360 | ) | $ | 100,687 | $ | 1,105,341 | |||||||||||||||
|
Nine Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash
flows from operating activities:
|
||||||||
|
Net
income
|
$ | 86,159 | $ | 55,394 | ||||
|
Depreciation
of property and equipment
|
972 | 1,008 | ||||||
|
Amortization
of trademarks and other intangibles
|
6,543 | 5,361 | ||||||
|
Amortization
of deferred financing costs
|
1,711 | 1,738 | ||||||
|
Amortization
of convertible note discount
|
11,019 | 10,431 | ||||||
|
Stock-based
compensation expense
|
6,562 | 4,993 | ||||||
|
Change
in non-controlling interest
|
- | (897 | ) | |||||
|
Allowance
for doubtful accounts
|
2,161 | 3,396 | ||||||
|
Earnings
on equity investment in joint venture
|
(2,242 | ) | (2,468 | ) | ||||
|
Realization
of cash flow hedge
|
134 | 148 | ||||||
|
Gain
on sale of trademark
|
- | (3,723 | ) | |||||
|
Deferred
income taxes
|
10,539 | 15,899 | ||||||
|
Changes
in operating assets and liabilities, net of business
acquisitions:
|
||||||||
|
Accounts
receivable
|
(3,524 | ) | (10,523 | ) | ||||
|
Other
assets - current
|
(193 | ) | 1,136 | |||||
|
Other
assets
|
(6,191 | ) | (3,983 | ) | ||||
|
Deferred
revenue
|
(6,060 | ) | 4,884 | |||||
|
Accounts
payable and accrued expenses
|
15,371 | (3,116 | ) | |||||
|
Other
long-term liabilities
|
5,711 | 884 | ||||||
|
Net
cash provided by operating activities
|
128,672 | 80,562 | ||||||
|
Cash
flows used in investing activities:
|
||||||||
|
Purchases
of property and equipment
|
(691 | ) | (1,789 | ) | ||||
|
Additions
to trademarks
|
(31 | ) | (114 | ) | ||||
|
Acquisition
of interest in Hardy Way
|
- | (9,000 | ) | |||||
|
Acquisition
of interest in MG Icon
|
(4,000 | ) | - | |||||
|
Acquisition
of Peanuts Worldwide
|
(172,054 | ) | - | |||||
|
Payment
of expenses related to acquisitions
|
(1,177 | ) | (223 | ) | ||||
|
Net
distributions from joint venture partners
|
1,738 | 991 | ||||||
|
Earn-out
payment on acquisition
|
(799 | ) | (9,400 | ) | ||||
|
Net
cash used in investing activities
|
(177,014 | ) | (19,535 | ) | ||||
|
Cash
flows used in financing activities:
|
||||||||
|
Proceeds
from issuance of new stock, net of cost
|
- | 152,787 | ||||||
|
Proceeds
from exercise of stock options and warrants
|
1,006 | 3,229 | ||||||
|
Shares
repurchased on vesting of restricted stock and exercise of stock
options
|
(499 | ) | (243 | ) | ||||
|
Shares
repurchased on the open market
|
- | (1,455 | ) | |||||
|
Payment
of long-term debt
|
(72,669 | ) | (55,200 | ) | ||||
|
Non-controlling
interest contribution
|
14,826 | 2,066 | ||||||
|
Excess
tax benefit from share-based payment arrangements
|
1,589 | 3,941 | ||||||
|
Restricted
cash - current
|
3,291 | (6,502 | ) | |||||
|
Net
cash (used in) provided by financing activities
|
(52,456 | ) | 98,623 | |||||
|
Net
decrease in cash and cash equivalents
|
(100,798 | ) | 159,650 | |||||
|
Cash,
beginning of period
|
195,381 | 66,404 | ||||||
|
Cash,
end of period
|
$ | 94,583 | $ | 226,054 | ||||
|
Balance
of restricted cash - current
|
2,872 | 7,377 | ||||||
|
Total
cash including current restricted cash, end of period
|
$ | 97,455 | $ | 233,431 | ||||
|
Nine Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash
paid during the period:
|
||||||||
|
Income
taxes
|
$ | 18,920 | $ | 8,023 | ||||
|
Interest
|
$ | 15,380 | $ | 15,645 | ||||
|
Nine Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Acquisitions:
|
||||||||
|
Common
stock issued
|
$ | 9,689 | $ | 23,675 | ||||
|
(000’s
omitted)
|
||||
|
Cash
paid to sellers
|
$
|
63,500
|
||
|
Fair
value of 49% non-controlling interest to sellers
|
57,959
|
|||
|
$
|
121,459
|
|
(000’s
omitted)
|
||||
|
Trademarks
|
$
|
203,515
|
||
|
License
agreements
|
6,830
|
|||
|
Non-compete
agreement
|
400
|
|||
|
Goodwill
|
714
|
|||
|
Long-term
debt issued
|
(90,000
|
)
|
||
|
$
|
121,459
|
|
(000’s
omitted)
|
||||
|
Cash
paid to sellers by Iconix Brand Group, Inc.
|
$
|
138,054
|
||
|
Fair
value of 20% non-controlling interest
|
33,378
|
|||
|
$
|
171,432
|
|||
|
Trademarks
and Copyrights
|
$
|
153,000
|
||
|
License
agreements
|
1,080
|
|||
|
Furniture,
fixtures and equipment
|
2,783
|
|||
|
Goodwill
|
17,515
|
|||
|
Cash
|
1,494
|
|||
|
Accounts
receivable
|
7,169
|
|||
|
Other
assets - current
|
6,567
|
|||
|
Deferred
revenue
|
(9,685
|
)
|
||
|
Accrued
artist royalties
|
(7,823
|
)
|
||
|
Other
current liabilities
|
(668
|
)
|
||
|
$
|
171,432
|
|
Carrying Amount as of
|
||||||||||||||
|
September
30, 2010
|
Valuation
|
|||||||||||||
|
(
000's omitted
)
|
Level 1
|
Level 2
|
Level 3
|
Technique
|
||||||||||
|
Marketable
Securities
|
$ | - | $ | - | $ | 7,284 |
(B)
|
|||||||
|
Carrying Amount as of
|
||||||||||||||
|
December
31, 2009
|
Valuation
|
|||||||||||||
|
(
000's omitted
)
|
Level 1
|
Level 2
|
Level 3
|
Technique
|
||||||||||
|
Marketable
Securities
|
$ | - | $ | - | $ | 6,988 |
(B)
|
|||||||
|
Cash
Flow Hedge
|
$ | - | $ | 1 | $ | - |
(A)
|
|||||||
|
Auction Rate Securities
|
(000's omitted)
|
|||||||
|
2010
|
2009
|
|||||||
|
Balance
at January 1
|
$ | 6,988 | $ | 7,522 | ||||
|
Additions
|
- | - | ||||||
|
Gains
(losses) reported in earnings
|
- | - | ||||||
|
Gains
(losses) reported in accumulated other comprehensive loss
|
296 | (66 | ) | |||||
|
Balance
at September 30
|
$ | 7,284 | $ | 7,456 | ||||
|
(000's omitted)
|
September 30, 2010
|
December 31, 2009
|
||||||||||||||
|
Carrying Amount
|
Fair Value
|
Carrying Amount
|
Fair Value
|
|||||||||||||
|
Long-term
debt, including current portion
|
$
|
601,174
|
$
|
620,623
|
$
|
662,379
|
$
|
650,732
|
||||||||
|
September 30, 2010
|
December 31, 2009
|
||||||||||||||||||
|
Estimated
|
Gross
|
Gross
|
|||||||||||||||||
|
Lives in
|
Carrying
|
Accumulated
|
Carrying
|
Accumulated
|
|||||||||||||||
|
(000's omitted)
|
Years
|
Amount
|
Amortization
|
Amount
|
Amortization
|
||||||||||||||
|
Indefinite
life trademarks and copyrights
|
Indefinite
(1)
|
$ | 1,382,725 | $ | 9,498 | $ | 1,229,695 | $ | 9,498 | ||||||||||
|
Definite
life trademarks
|
10-15
|
19,571 | 4,805 | 19,571 | 3,715 | ||||||||||||||
|
Non-compete
agreements
|
2-15
|
10,475 | 8,752 | 10,475 | 7,644 | ||||||||||||||
|
Licensing
agreements
|
1-9
|
30,103 | 17,596 | 29,023 | 13,338 | ||||||||||||||
|
Domain
names
|
5
|
570 | 536 | 570 | 450 | ||||||||||||||
| $ | 1,443,444 | $ | 41,187 | $ | 1,289,334 | $ | 34,645 | ||||||||||||
|
September 30,
|
December 31,
|
|||||||
|
(000’s
omitted)
|
2010
|
2009
|
||||||
|
Convertible
Notes
|
$ | 258,715 | $ | 247,696 | ||||
|
Term
Loan Facility
|
170,873 | 217,632 | ||||||
|
Ecko
Note
|
82,500 | 90,000 | ||||||
|
Asset-Backed
Notes
|
76,900 | 94,865 | ||||||
|
Sweet
Note
|
12,186 | 12,186 | ||||||
|
Total
|
$ | 601,174 | $ | 662,379 | ||||
|
September 30,
|
December 31,
|
|||||||
|
(000’s omitted)
|
2010
|
2009
|
||||||
|
Equity
component carrying amount
|
$ | 41,309 | $ | 41,309 | ||||
|
Unamortized
discount
|
28,785 | 39,804 | ||||||
|
Net
debt carrying amount
|
258,715 | 247,696 | ||||||
|
(000’s
omitted)
|
Total
|
October
1
through
December
31,
2010
|
2011
|
2012
|
2013
|
2014
|
||||||||||||||||||
|
Convertible
Notes
(1)
|
$ | 258,715 | $ | - | $ | - | $ | 258,715 | $ | - | $ | - | ||||||||||||
|
Term
Loan Facility
|
170,873 | - | 44,736 | 126,137 | - | - | ||||||||||||||||||
|
Ecko
Note
|
82,500 | 2,500 | 10,000 | 10,000 | 10,000 | 50,000 | ||||||||||||||||||
|
Asset-Backed
Notes
|
76,900 | 6,251 | 26,380 | 33,468 | 10,801 | - | ||||||||||||||||||
|
Sweet
Note
|
12,186 | 12,186 | - | - | - | - | ||||||||||||||||||
|
Total
|
$ | 601,174 | $ | 20,937 | $ | 81,116 | $ | 428,320 | $ | 20,801 | $ | 50,000 | ||||||||||||
|
Expected
Volatility
|
30 - 45 | % | ||
|
Expected
Dividend Yield
|
0 | % | ||
|
Expected
Life (Term)
|
3 -
7 years
|
|||
|
Risk-Free
Interest Rate
|
3.00 - 4.75 | % | ||
|
Options
|
Weighted-Average
|
|||||||
|
Options
|
Exercise Price
|
|||||||
|
Outstanding
January 1, 2010
|
3,094,079 | $ | 4.48 | |||||
|
Granted
|
15,000 | 16.33 | ||||||
|
Canceled
|
- | - | ||||||
|
Exercised
|
(349,700 | ) | 2.89 | |||||
|
Expired
|
(16,844 | ) | 1.31 | |||||
|
Outstanding
September 30, 2010
|
2,742,535 | $ | 5.39 | |||||
|
Exercisable
at September 30, 2010
|
2,739,201 | $ | 5.37 | |||||
|
Weighted-Average
|
||||||||
|
Warrants
|
Exercise Price
|
|||||||
|
Outstanding
January 1, 2010
|
286,900 | $ | 16.99 | |||||
|
Granted
|
- | - | ||||||
|
Canceled
|
- | - | ||||||
|
Exercised
|
- | - | ||||||
|
Expired/Forfeited
|
- | - | ||||||
|
Outstanding
September 30, 2010
|
286,900 | $ | 16.99 | |||||
|
Exercisable
at September 30, 2010
|
286,900 | $ | 16.99 | |||||
|
Weighted-Average
|
||||||||
|
Shares
|
Grant
Date
Fair
Value
|
|||||||
|
Non-vested,
January 1, 2010
|
2,041,126 | $ | 17.28 | |||||
|
Granted
|
336,520 | 14.43 | ||||||
|
Vested
|
(65,127 | ) | 16.09 | |||||
|
Forfeited/Canceled
|
(1,266 | ) | 7.90 | |||||
|
Non-vested,
September 30, 2010
|
2,311,253 | $ | 16.90 | |||||
|
|
For the Three Months Ended
|
For the Nine Months Ended
|
||||||||||||||
|
(000's omitted)
|
September 30,
(unaudited)
|
September 30,
(unaudited)
|
||||||||||||||
|
|
2010
|
2009
|
2010
|
2009
|
||||||||||||
|
Basic
|
72,326 | 71,336 | 72,013 | 63,850 | ||||||||||||
|
Effect
of exercise of stock options
|
1,980 | 2,436 | 1,960 | 2,246 | ||||||||||||
|
Effect
of contingent common stock issuance
|
- | - | 48 | 48 | ||||||||||||
|
Effect
of assumed vesting of restricted stock
|
614 | 298 | 611 | 282 | ||||||||||||
|
Diluted
|
74,920 | 74,070 | 74,632 | 66,426 | ||||||||||||
|
For the three months ended
|
For the nine months ended
|
|||||||||||||||
|
(000's
omitted)
|
September
30,
(unaudited)
|
September
30,
(unaudited)
|
||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenues
by product line:
|
||||||||||||||||
|
Direct-to-retail
license
|
$ | 35,574 | $ | 29,908 | $ | 112,337 | $ | 83,934 | ||||||||
|
Wholesale
license
|
41,784 | 24,850 | 111,725 | 76,888 | ||||||||||||
|
Entertainment and
other
|
19,529 | 4,609 | 20,542 | 5,454 | ||||||||||||
| $ | 96,887 | $ | 59,367 | $ | 244,604 | $ | 166,276 | |||||||||
|
Revenues
by geographic region:
|
||||||||||||||||
|
United
States
|
$ | 80,990 | $ | 53,199 | $ | 218,914 | $ | 154,914 | ||||||||
|
Other
|
15,897 | 6,168 | 25,690 | 11,362 | ||||||||||||
| $ | 96,887 | $ | 59,367 | $ | 244,604 | $ | 166,276 | |||||||||
|
|
•
|
could
impair our liquidity;
|
|
|
•
|
could
make it more difficult for us to satisfy our other
obligations;
|
|
|
•
|
require
us to dedicate a substantial portion of our cash flow to payments on our
debt obligations, which reduces the availability of our cash flow to fund
working capital, capital expenditures and other corporate
requirements;
|
|
|
•
|
could
impede us from obtaining additional financing in the future for working
capital, capital expenditures, acquisitions and general corporate
purposes;
|
|
|
•
|
impose
restrictions on us with respect to the use of our available cash,
including in connection with future
acquisitions;
|
|
|
•
|
make
us more vulnerable in the event of a downturn in our business prospects
and could limit our flexibility to plan for, or react to, changes in our
licensing markets; and
|
|
|
•
|
could
place us at a competitive disadvantage when compared to our competitors
who have less debt.
|
|
|
•
|
unanticipated
costs associated with the target
acquisition;
|
|
|
•
|
negative
effects on reported results of operations from acquisition related charges
and amortization of acquired
intangibles;
|
|
|
•
|
diversion
of management’s attention from other business
concerns;
|
|
|
•
|
the
challenges of maintaining focus on, and continuing to execute, core
strategies and business plans as our brand and license portfolio grows and
becomes more diversified;
|
|
|
•
|
adverse
effects on existing licensing
relationships;
|
|
|
•
|
potential
difficulties associated with the retention of key employees, and the
assimilation of any other employees, who may be retained by us in
connection with or as a result of our acquisitions;
and
|
|
|
•
|
risks
of entering new domestic and international markets (whether it be with
respect to new licensed product categories or new licensed product
distribution channels) or markets in which we have limited prior
experience.
|
|
Month of purchase
|
Total number
of shares
purchased
|
Average
price
paid per share
|
Total number
of
shares
purchased as
publicly
announced
plans or
programs
(1)
|
Maximum
number
(or approximate
dollar
value) of
shares
that may yet
be
purchased
under the
plans or
programs
|
||||||||||||
|
July
1 – July 31
|
309 | $ | 16.99 | $ | - | $ | 71,722,003 | |||||||||
|
August
1 – August 31
|
110,687 | $ | 15.50 | $ | - | $ | 71,722,003 | |||||||||
|
September
1 – September 30
|
- | $ | - | $ | - | $ | 71,722,003 | |||||||||
|
Total
|
110,996 | $ | 15.50 | $ | - | $ | 71,722,003 | |||||||||
|
EXHIBIT NO.
|
DESCRIPTION OF EXHIBIT
|
|
|
Exhibit
31.1
|
Certification
of Chief Executive Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The
Sarbanes-Oxley Act of 2002
|
|
|
Exhibit
31.2
|
Certification
of Chief Financial Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 Of The
Sarbanes-Oxley Act of 2002
|
|
|
Exhibit
32.1
|
Certification
of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002
|
|
|
Exhibit
32.2
|
Certification
of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002
|
|
Iconix
Brand Group, Inc.
(Registrant)
|
|
|
Date:
November 4, 2010
|
/s/
Neil Cole
|
|
Neil
Cole
Chairman
of the Board, President
and
Chief Executive Officer
(on
Behalf of the Registrant)
|
|
Date:
November 4, 2010
|
/s/
Warren Clamen
|
|
Warren
Clamen
Executive
Vice President
and
Chief Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|